Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TTR | P02766 | 1/20 | 0.53 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.53 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.53 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | HPGD | P15428 | 1/20 | 0.47 |
| ▸ | NFE2L2 | Q16236 | 3/20 | 0.47 |
| ▸ | CHAT | P28329 | 3/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | RAB9A | P51151 | 1/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.44 |
| ▸ | MAOB | P27338 | 2/20 | 0.42 |
| ▸ | RELA | Q04206 | 2/20 | 0.42 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.42 |
| ▸ | MAOA | P21397 | 1/20 | 0.42 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL698718 | 1.00 | TTR (0.53) | TTRALOX5PTGS1PTGS2KDM4E | |
| SCHEMBL28524007 | 0.87 | TTR (0.46) | TTRALOX5PTGS1PTGS2KDM4E | |
| Benzoic Acid SCHEMBL20968915 | 0.86 | TTR (0.51) | TTRALOX5PTGS1PTGS2ALDH1A1 | |
| SCHEMBL12500811 | 0.82 | NFE2L2 (0.56) | TTRALOX5PTGS1PTGS2KDM4E | |
| SCHEMBL12500812 | 0.82 | NFE2L2 (0.56) | TTRALOX5PTGS1PTGS2KDM4E | |
| SCHEMBL699401 | 0.81 | RAPGEF4 (0.43) | KDM4EALDH1A1HPGDMAPT | |
| SCHEMBL699400 | 0.81 | RAPGEF4 (0.43) | KDM4EALDH1A1HPGDMAPT | |
| SCHEMBL12500726 | 0.79 | ALOX5 (0.59) | TTRALOX5PTGS1PTGS2KDM4E | |
| SCHEMBL12500728 | 0.79 | ALOX5 (0.59) | TTRALOX5PTGS1PTGS2KDM4E | |
| SCHEMBL27969136 | 0.79 | ALOX5 (0.59) | TTRALOX5PTGS1PTGS2KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 52 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0460994-B1 | Method and apparatus to make evident one or more shocks received by a substrate | HUTCHINSON SA (FR) | 1995-03-15 | — | — | EP | claimed |
| US-5242830-A | Detection of impact with fluorescent indicators by embedding microcapsules and releasing | HUTCHINSON (FR) | 1993-09-07 | — | — | US | claimed |
| EP-0460994-A1 | Method and apparatus to make evident one or more shocks received by a substrate | HUTCHINSON S.A. une SociÀ©té Anonyme dotée d'un Conseil de Surveillance et d'un Directoire (FR) | 1991-12-11 | — | — | EP | claimed |
| US-12404221-B2 | Methods of arene alkenylation | UNIVERSITY OF VIRGINIA PATENT FOUNDATION (US) | 2025-09-02 | — | — | US | disclosed |
| US-20230234900-A1 | METHODS OF ARENE ALKENYLATION | UNIVERSITY OF VIRGINIA PATENT FOUNDATION | 2023-07-27 | — | — | US | disclosed |
| WO-2021074275-A1 | EFFECTIVE PHOTOMODULATION OF LANTHANIDE (III) ION LUMINESCENCE IN THE VISIBLE OR NEAR-INFRARED RANGE | UNIVERSITE DE RENNES 1 (FR) | 2021-04-22 | — | — | WO | disclosed |
| US-9925153-B2 | Therapeutic agents for skin diseases and conditions | STC.UNM (US) | 2018-03-27 | — | — | US | disclosed |
| US-9868873-B2 | Photochromic security enabled ink for digital offset printing applications | XEROX CORPORATION (US) | 2018-01-16 | — | — | US | disclosed |
| US-20160287531-A1 | THERAPEUTIC AGENTS FOR SKIN DISEASES AND CONDITIONS | STC.UNM | 2016-10-06 | — | — | US | disclosed |
| US-8980954-B2 | Substituted cis- and trans-stilbenes as therapeutic agents | STC.UNM (US) | 2015-03-17 | — | — | US | disclosed |
| US-8703388-B2 | Optical data storage media | GENERAL ELECTRIC COMPANY (US) | 2014-04-22 | — | — | US | disclosed |
| EP-1591830-A2 | Reimageable medium | Xerox Corporation (US) | 2005-11-02 | — | — | EP | disclosed |
| US-5759729-A | A DRY TONER COMPRISING A RESIN, PHOTOCHROMATIC SPIROPYRAN, -OXAZINE OR -THIOPYRAN DYE AND A CHARGE CONTROL AGENT;ELECTROGRAPHY; XEROGRAPHY | XEROX CORPORATION (US) | 1998-06-02 | — | — | US | disclosed |
| US-5710420-A | Method for embedding and recovering machine-readable information | XEROX CORPORATION (US) | 1998-01-20 | — | — | US | disclosed |
| US-5633109-A | Ink compositions with liposomes containing photochromic compounds | XEROX CORPORATION (US) | 1997-05-27 | — | — | US | disclosed |
| US-5593486-A | Photochromic hot melt ink compositions | XEROX CORPORATION (US) | 1997-01-14 | — | — | US | disclosed |
| US-5551973-A | LIQUID CRYSTAL GEL PHASE, MICROEMULSION PHASE | XEROX CORPORATION (US) | 1996-09-03 | — | — | US | disclosed |
| EP-0460994-B1 | Method and apparatus to make evident one or more shocks received by a substrate | HUTCHINSON SA (FR) | 1995-03-15 | — | — | EP | disclosed |
| US-5242830-A | Detection of impact with fluorescent indicators by embedding microcapsules and releasing | HUTCHINSON (FR) | 1993-09-07 | — | — | US | disclosed |
| EP-0460994-A1 | Method and apparatus to make evident one or more shocks received by a substrate | HUTCHINSON S.A. une SociÀ©té Anonyme dotée d'un Conseil de Surveillance et d'un Directoire (FR) | 1991-12-11 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160287531-A1 | THERAPEUTIC AGENTS FOR SKIN DISEASES AND CONDITIONS | CUTA, TSLP, ELANE | TTR 76/4885ALOX5 977/4885PTGS1 1081/4885 |
| US-20230234900-A1 | METHODS OF ARENE ALKENYLATION | CYBB, CBR3, AHR | TTR 2602/4885ALOX5 117/4885PTGS1 2007/4885 |
| US-12404221-B2 | Methods of arene alkenylation | CYBB, CBR3, AHR | TTR 2602/4885ALOX5 117/4885PTGS1 2007/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.